All-trans Retinoic Acid Inhibited Angiotensin II-induced Increase in Cell Growth and Collagen Secretion of Neonatal Cardiac Fibroblasts.

Yan He,Ying Huang,Li Zhou,Li-min Lu,Yi-chun Zhu,Tai Yao

DOI: https://doi.org/10.1111/j.1745-7254.2006.00296.x

IF: 7.169

2006-01-01

Acta Pharmacologica Sinica

Abstract:To determine whether all-trans retinoic acid (atRA) acts to modulate angiotensin II (Ang II)-induced cardiac fibroblast cell growth and collagen secretion. Cultured neonatal rat cardiac fibroblasts (CF) were used in the experiment. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to detect cell growth of the CF; and immunocytochemistry and Western blotting were used to measure the production and secretion of collagen and the expression of transforming growth factor-β1 (TGF-β1) by the CF. atRA (1 × 10−7 to 1 × 10−5 mol/L) inhibited the Ang II-induced increase in cell growth of CF (P<0.05). Ang II stimulated the secretion of collagen types I and III by the CF. This effect was blocked by AT1 receptor antagonist losartan (1 × 10−6 mol/L), but not by AT2 receptor antagonist PD123319 (up to 1 × 10−6 mol/L). Exposure of CF to atRA (1 × 10−5 mol/L) attenuated the Ang II-induced increase in the secretion of collagen types I and III (P<0.05). atRA (1 × 10−5 mol/L) also blocked the Ang II-induced increase in the expression of TGF-β1 atRA inhibits the Ang II-induced increase in cell growth and collagen secretion of neonatal rat CF. The effect of atRA is possibly mediated by lowering the TGF-β1 level. These observations support the notion that atRA is a potential candidate for the prevention and therapy of cardiac remodeling.